期刊文献+

卵巢上皮癌中HLA-DR及HLA-ABC表达的临床意义 被引量:1

Clinical Significance of Expression of HLA-DR and HLA-ABC Antigens in Epithelial Ovarian Carcinoma
下载PDF
导出
摘要 【目的】研究卵巢上皮癌(EOC)中HLA-DR及HLA-ABC的表达及其临床意义,为以HLA为靶点的肿瘤免疫治疗提供理论依据。【方法】应用免疫组织化学SP法检测57例卵巢上皮癌、35例卵巢良性上皮肿瘤及20例正常卵巢组织中HLA-DR及HLA-ABC的表达情况。【结果】①卵巢癌HLA-DR阳性率(33/57)显著高于良性肿瘤(4/35)及正常卵巢组织(1/20),P<0.05;Ⅰ期卵巢癌HLA-DR的阳性率显著高于Ⅲ期与Ⅳ期,P<0.01;高分化组HLA-DR的阳性率显著高于中、低分化组,P<0.05。②卵巢癌HLA-ABC的阳性率(37/57)显著低于良性肿瘤(30/35)及正常卵巢组织(20/20),P<0.05;Ⅰ期卵巢癌HLA-ABC的阳性率显著高于Ⅲ期与Ⅳ期,P<0.01。③HLA-DR及HLA-ABC的阳性率与卵巢癌患者的生存率均呈正相关,阳性表达组的生存率明显高于阴性组,P<0.05。【结论】HLA-DR、HLA-ABC异常表达可能与卵巢癌的发生发展有关;HLA-DR及HLA-ABC可以作为评估卵巢癌预后的指标之一。 To investigate the significance of HLA-DR and HLA-ABC antigen expression in ovarian epithelial carcinoma and to provide the theoretic al basis on tumor immune therapy targeting HLA.Streptomyces avidin-peroxidase(S-P)immunohistochemical method was used to detect the HLA-DR a nd HLA-ABC antigen expression in normal ovarian tissues,benign and ovarian carcinomas.①The positive rate of HLA-DR in ovaria n carcinomas was obviously higher than those in benig n ovarian tumor and normal ovarian tissues,which was obviously higher in stageⅠthan that in stageⅢ&Ⅳ;The positive rate of HLA-DR was obviously higher in high differentiated group than those in m edian and low differentiated groups.②The positive rate of HLA-ABC in ovarian carcinomas was ob viously lower than those in benign ovarian tumor and normal ovarian tissues,which was obviously higher in stageⅠthan that in stageⅢ&Ⅳ.③The positive rate of HLA-DR&HLA-ABC were positively c orrelated with the survival rate of o varian carcinoma.[Conclusion]The abnormal expression of HLA-DR &H LA-ABC may be associated with the pathogenesis of ovarian carcinoma.HLA-DR &HLA-ABC may be the prognostic factors of ovarian epithelial carcinoma.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2004年第5期481-485,共5页 Journal of Sun Yat-Sen University:Medical Sciences
关键词 HLA-DR HLA-A 卵巢癌 阳性率 卵巢上皮癌 卵巢组织 正常 表达 分化 ovarian tumor histocompatibility antigen prognosis immunohistoch emistry
  • 相关文献

参考文献7

  • 1Beck S, Aguado B, Bahram S, et al. Complete sequence and gene map of a human major histocompatibility complex the MHC sequencing consortium[J]. Nature, 1999, 401(6756): 921-3.
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1367
  • 3沈文律,夏仁品.HLA-DR抗原在结肠癌组织中的表达及其意义[J].中华普通外科杂志,2000,15(3):142-144. 被引量:7
  • 4肖国宏,陈惠祯,张桂清,郑秀玲.HLA-DR在上皮性卵巢癌中的表达及意义[J].实用医学杂志,2001,17(2):112-113. 被引量:5
  • 5Matsushita N, Ghazizadeh M, Konishi H, et al. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes[J] .J Nippon Med Sch, 2003 , 70(1): 40-4.
  • 6Ostrand-Rosenberg S, Thakur A, Clements V. Rejection of mouse sarcoma cells after transfection of MHC class Ⅱ genes[J]. J Immunol, 1990, 144(10): 4068-71.
  • 7Tait B D. HLA class I expression on human cancer cells.Implications for effective immunotherapy[J] . Hum Immunol,2000, 61 (2): 158-65.

二级参考文献10

共引文献1376

同被引文献20

  • 1周奕,张丙忠,周晖,林仲秋.子宫内膜癌HLA-DR表达及其临床意义[J].肿瘤学杂志,2004,10(5):296-298. 被引量:3
  • 2Lee YS, Kim TE, Kim BK, et al. Alterations of HLA class Ⅰ and class Ⅱ antigen expressions in borderline, invasive and metastatic ovarian cancers[J]. J Nippon Med Sch, 2003,70(2) : 40 -44.
  • 3Tamiolakis D, Kotini A, Venizelos J, et al. Prognostic significance of HLA - DR antigen in serous ovarian tumors[ J]. Clin Exp Med, 2003 ,3(2) : 113-118.
  • 4Rangel LB, Agarwal R, Sherman - Baust CA, et al. Anomalous expression of the HLA - DR alpha and beta chains in ovarian and other cancers [ J ]. Cancer Biol Ther, 2004,3 (10) : 1021 - 1027.
  • 5Hachisuga T, Fukuda K, Nakamura S, et al. Local immune response in endometrial carcinomas [ J ]. Br J Obstet Gynaecol, 1997,104(1) : 110-114.
  • 6Lazaris AC, Chatzigianni EB, Xidias G,et al. Tissue evaluation of immune markers in endometrial and cervical carcinomas [ J ]. J Exp Clin Cancer Res,2004 , 23 (2) : 269 - 275.
  • 7Tamiolakis D, Venizelos J, Lambropoulou M, et al. Local immune response in serous papillary carcinoma of the endometrium [ J]. Histol Histopathol,2005 ,20(2) : 403 -408.
  • 8Maciag PC, Schlecht NF, Souza PS , et al. Major histocompatibility complex and human papillomavirus infection in Brazilian women[ J]. Cancer Epidemiol Biomakers Prey, 2000,9 ( 11 ) : 1183 - 1191.
  • 9Chil A, Sikorski M, Bobek M,et al. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix[J]. Acta Obstet Gynecol Scand, 2003 ,82(12) :1146 - 1152.
  • 10Ryu KS, Lee YS,Kim BK, et al. Alterations of HLA class Ⅰ and Ⅱ antigen expression in preinvasive, invasive and metastatic cervical cancers[J]. Exp and Mol Med, 2001,33(3) : 136-144.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部